What Did Pharma Learn from the COVID-19 Pandemic
In this session, with 2020 in the rear view mirror and 2021 in full swing, speakers discuss lessons learned by pharma during the pandemic and the role digital health, interoperability, and real world evidence will play in reshaping clinical trials and accelerating drug development.
Key discussion points:
• Lessons learned by Pharma during the pandemic.
• How pharma can better partner with healthcare providers to optimize real world evidence.
• Keys to reducing costs and time-to-market for pharmaceutical companies.
• How AI can help manage large amounts of data.